Long-term Outcome for Patients with Advanced Non‒small-Cell Lung Cancer Treated by Autologous Cytokine-Induced Killer (CIK) Cell Immunotherapy in Combination with Sintilimab Plus Chemotherapy: NSCLC-CCICC-002.
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要